Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Indian J Pharmacol. 2013 Jan-Feb;45(1):98-9. doi: 10.4103/0253-7613.106448.
An 18 year old male diagnosed as a case of bipolar affective disorder (BPAD), developed neuroleptic malignant syndrome (NMS) following treatment with olanzapine (20 mg per day), an atypical antipsychotic drug. NMS is usually seen with typical antipsychotic drugs. The patient was diagnosed as a case of NMS, offending agent was immediately withdrawn and prompt treatment with bromocriptine and levodopa produced a good recovery. The various features of the case are discussed in view of the potential mortality of the syndrome.
一位 18 岁男性被诊断为双相情感障碍（BPAD）病例，在接受奥氮平（每天 20 毫克）治疗后出现了神经阻滞剂恶性综合征（NMS），奥氮平是一种非典型抗精神病药物。通常情况下，典型的抗精神病药物会引起 NMS。该患者被诊断为 NMS 病例，立即停用致病药物，并用溴隐亭和左旋多巴进行迅速治疗后恢复良好。鉴于该综合征的潜在死亡率，对该病例的各种特征进行了讨论。
